Kewaunee Scientific Corp Files 8-K on Financials
Ticker: KEQU · Form: 8-K · Filed: Jun 26, 2024 · CIK: 55529
| Field | Detail |
|---|---|
| Company | Kewaunee Scientific CORP /De/ (KEQU) |
| Form Type | 8-K |
| Filed Date | Jun 26, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $2.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-reporting, 8-K
Related Tickers: KEQU
TL;DR
KEQU filed an 8-K on 6/26 detailing financials. Check it out.
AI Summary
Kewaunee Scientific Corporation filed an 8-K on June 26, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to its business operations. The company is incorporated in Delaware and headquartered in Statesville, NC.
Why It Matters
This filing provides investors with crucial updates on Kewaunee Scientific's financial performance and operational status, impacting investment decisions.
Risk Assessment
Risk Level: low — This is a routine 8-K filing providing financial information, not indicating any immediate operational or financial distress.
Key Players & Entities
- Kewaunee Scientific Corporation (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Statesville, NC (location) — Principal executive offices
- June 26, 2024 (date) — Date of report
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Kewaunee Scientific Corporation's results of operations and financial condition, including financial statements and exhibits.
When was this 8-K report filed?
This 8-K report was filed on June 26, 2024.
Where is Kewaunee Scientific Corporation's principal executive office located?
Kewaunee Scientific Corporation's principal executive office is located at 2700 West Front Street, Statesville, NC 28677.
In which state is Kewaunee Scientific Corporation incorporated?
Kewaunee Scientific Corporation is incorporated in Delaware.
What is the SIC code for Kewaunee Scientific Corporation?
The Standard Industrial Classification (SIC) code for Kewaunee Scientific Corporation is 3821, which pertains to Laboratory Apparatus & Furniture.
Filing Stats: 536 words · 2 min read · ~2 pages · Grade level 12.5 · Accepted 2024-06-26 16:44:55
Key Financial Figures
- $2.50 — ange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Marke
Filing Documents
- kequ-20240626.htm (8-K) — 31KB
- prfy24q4earningsrelease.htm (EX-99.1) — 274KB
- logo_stackedxdark.jpg (GRAPHIC) — 280KB
- 0000055529-24-000018.txt ( ) — 815KB
- kequ-20240626.xsd (EX-101.SCH) — 2KB
- kequ-20240626_lab.xml (EX-101.LAB) — 21KB
- kequ-20240626_pre.xml (EX-101.PRE) — 12KB
- kequ-20240626_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition On June 26, 2024, Kewaunee Scientific Corporation issued a press release announcing financial results for its fourth quarter and its fiscal year ended April 30, 2024. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Kewaunee Scientific Corporation dated June 2 6, 2024 . 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. KEWAUNEE SCIENTIFIC CORPORATION (Registrant) Date: June 26, 2024 By /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance Chief Financial Officer